Pfm Health Sciences, LP Astrazeneca PLC Transaction History

Pfm Health Sciences, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $7.38 Million - $8.86 Million	124,500 Added 27.53%	576,800 $38.1 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $18.6 Million - $22.4 Million	-333,448 Reduced 42.44%	452,300 $30 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $32.1 Million - $35.1 Million	577,148 Added 276.68%	785,748 $47.2 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $29.1 Million - $36.2 Million	-601,800 Reduced 74.26%	208,600 $12.5 Million
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $13.4 Million - $15.5 Million	-284,200 Reduced 25.96%	810,400 $40.3 Million
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $34.3 Million - $41 Million	706,700 Added 182.19%	1,094,600 $54.7 Million
Q3 2020 Nov 16, 2020	SELL	$53.07 - $61.1 $13.1 Million - $15.1 Million	-247,700 Reduced 38.97%	387,900 $21.3 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $27.4 Million - $35.2 Million	635,600 New	635,600 $33.6 Million

1,334

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $218B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.